Table 1.
Patient demographics
| Characteristic | Patients (N = 92) |
|---|---|
| Sex at birth, n (%) | |
| Male | 36 (39.1) |
| Female | 56 (60.9) |
| Age at MG diagnosis, years | |
| Mean (SD) | 47.6 (19.3) |
| Median (IQR) | 50.5 (35–64) |
| Race, n (%) | |
| White | 70 (76.1) |
| Black/African American | 18 (19.6) |
| Asian | 2 (2.2) |
| American Indian/Alaskan Native | 1 (1.1) |
| Other | 1 (1.1) |
| Insurance status at eculizumab initiation, n (%)a | |
| Medicare | 42 (45.7) |
| Medicaid | 8 (8.7) |
| Commercial | 45 (48.9) |
| Military | 2 (2.2) |
| Unknown | 0 |
IQR interquartile range, MG myasthenia gravis, SD standard deviation
aCategories not mutually exclusive